Literature DB >> 4570387

3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.

M D Muenter, R P Dinapoli, N S Sharpless, G M Tyce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4570387

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  10 in total

Review 1.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

2.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

4.  Influence of L-3-methoxytyrosine on monoamine synthesis in rat brain.

Authors:  W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

5.  In vivo effects of new inhibitors of catechol-O-methyl transferase.

Authors:  E Rivas; M L de Ceballos; O Nieto; J A Fontenla
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

6.  Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.

Authors:  M Merello; A J Lees; R Webster; M Bovingdon; A Gordin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

7.  Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.

Authors:  L Rivera-Calimlim
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

8.  Low catechol-O-methyltransferase activity in a Saami population.

Authors:  B Klemetsdal; B Straume; T Giverhaug; J Aarbakke
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.

Authors:  A Reches; D Jiang; S Fahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

10.  eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates.

Authors:  Limeng Pu; Misagh Naderi; Tairan Liu; Hsiao-Chun Wu; Supratik Mukhopadhyay; Michal Brylinski
Journal:  BMC Pharmacol Toxicol       Date:  2019-01-08       Impact factor: 2.483
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.